Robin Shivnaraine, PhD, Director of Clinical Pharmacology at Aerys Biosciences, attended the 25th Anniversary Summit of the Pulmonary Fibrosis Foundation in November 2025, held in Chicago, Illinois.The meeting brought together patients, clinicians, researchers, and industry leaders to mark 25 years of progress in pulmonary fibrosis research and care. During the Summit, Dr. Shivnaraine engaged with the PF community and clinical leaders to discuss emerging therapeutic strategies and ongoing clinical trial efforts in idiopathic pulmonary fibrosis (IPF).